MDTrials connects specialty CRO services with a growing Canadian clinical site network.
Clinical operations, monitoring, regulatory start-up, quality and site execution.
ABOUT US
Clinical development and site execution, connected.
MDTrials brings specialty CRO services and a growing Canadian clinical site network under one commercial brand.
Engage either service independently or connect them when earlier site insight and coordinated execution add value to your program.
Therapeutic focus
Our strongest experience sits in oncology, inflammatory bowel disease and hepatology. Additional experience includes dermatology, rare and genetic disease, and medical-device trials.
The scope differs by service line. Oncology is led by MDTrials CRO team experience and delivered through qualified external investigational sites. IBD is where CRO and site capability most directly intersect. MDTrials Sites continues to expand into additional specialties.

Specialty clinical operations for emerging and small-to-mid biopharma. We support early-phase and first-in-patient programs through regulatory start-up, clinical trial monitoring, project management, and GxP audit and inspection-readiness services. Our strongest therapeutic experience is in oncology, inflammatory bowel disease and hepatology, and we are clear about which functions we deliver directly and which we source through qualified partners under our oversight.

A growing network of Canadian research sites operating under one model, anchored by sites in Alberta, with additional sites in development. For sponsors and CROs, we provide realistic feasibility, site activation and coordinated site operations. For clinics and investigators, we build the infrastructure that makes research sustainable alongside clinical practice.
MDTrials can support a complete Canadian workstream or a focused functional engagement alongside your existing CRO structure.
- Independent GCP audit & inspection readiness
- Health Canada regulatory & study start-up
- Clinical trial monitoring
- Clinical project management
- Canadian site feasibility & execution
A Canadian study footprint is not required for independent quality and selected functional CRO engagements.
Top Four Reasons
Why MDTrials?

Accountable Ownership
Every study has a named accountable lead who remains closely involved with it through close-out and final study completion. Escalation paths are short and direct, and sponsor decisions are clearly documented rather than absorbed into layers.
CONTACT US
Tell us, what you are trying to move forward.
If you are planning a Canadian trial, need focused CRO support, are looking for research-ready sites, or want to build research within your clinic, start with the team closest to the work.



